Vesa M. Kaartinen

Dr. Vesa M. Kaartinen

University of Michigan–Ann Arbor, Ann Arbor, Michigan, USA
orcid

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 1995 in Nature Genetics
Verified
Journal Article
Closed access
VKVesa M. Kaartinen
Vesa M. Kaartinen
JVJan Willem Voncken
Jan Willem Voncken
CSCharles Shuler
Charles Shuler
DWDavid Warburton
David Warburton
DBDing Bu
Ding Bu
JGJohn Groffen
John Groffen

1 December 2011 in Cell
Verified
Journal Article
Closed access
QXQiaoran Xi
Qiaoran Xi
ZWZhanxin Wang
Zhanxin Wang
AZAlexia-Ileana Zaromytidou
Alexia-Ileana Zaromytidou
XZXiang H.-F. Zhang
Xiang H.-F. Zhang
LCLai-Fong Chow-Tsang
Lai-Fong Chow-Tsang
JMJoan Massagué
Joan Massagué

15 January 2008 in Blood
Verified
Journal Article
Open access
PDF file
SPSung O. Park
Sung O. Park
YLYoung Jae Lee
Young Jae Lee
TSTsugio Seki
Tsugio Seki
KHKwonho Hong
Kwonho Hong
NFNaime Fliess
Naime Fliess
SOS. Paul Oh
S. Paul Oh
ALK1 belongs to the type I receptor family for transforming growth factor-β family ligands. Heterozygous ALK1 mutations cause hereditary hemorrhagic telangiectasia type 2 (HHT2), a multisystemic vascular disorder. Based largely on in vitro studies, TGF-β1 has been considered as the most likely ALK1 ligand related to HHT, yet the identity of the physiologic ALK1 ligand remains controversial. In cultured endothelial cells, ALK1 and another TGF-β type I receptor, ALK5, regulate angiogenesis by controlling TGF-β signal transduction, and ALK5 is required for ALK1 signaling. However, the extent to which such interactions between these 2 receptors play a role in pathogenesis of HHT is unknown. We directly addressed these issues in vivo by comparing the phenotypes of mice in which the Alk1, Alk5, or Tgfbr2 gene was conditionally deleted in restricted vascular endothelia using a novel endothelial Cre transgenic line. Alk1-conditional deletion resulted in severe vascular malformations mimicking all pathologic features of HHT. Yet Alk5- or Tgfbr2-conditional deletion in mice, or Alk5 inhibition in zebrafish, did not affect vessel morphogenesis. These data indicate that neither ALK5 nor TGFBR2 is required for ALK1 signaling pertinent to the pathogenesis of HHT and suggest that HHT might not be a TGF-β subfamily disease.

1 February 2004 in Mechanisms of Development
Verified
Journal Article
Closed access
MDMarek Dudas
Marek Dudas
SSSomyoth Sridurongrit
Somyoth Sridurongrit
ANAndre Nagy
Andre Nagy
KOKenji Okazaki
Kenji Okazaki
VKVesa M. Kaartinen
Vesa M. Kaartinen

2 September 2007 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
WZWenlai Zhou
Wenlai Zhou
LLLizhu Lin
Lizhu Lin
AMArindam Majumdar
Arindam Majumdar
XLXue Li
Xue Li
XZXiaoxue Zhang
Xiaoxue Zhang
SESylvia M Evans
Sylvia M Evans

15 July 2004 in Development
Verified
Journal Article
Open access
PDF file
VKVesa M. Kaartinen
Vesa M. Kaartinen
MDMarek Dudas
Marek Dudas
ANAndre Nagy
Andre Nagy
SSSomyoth Sridurongrit
Somyoth Sridurongrit
MLMin Min Lu
Min Min Lu
JEJonathan A. Epstein
Jonathan A. Epstein
Cardiac neural crest cells are multipotent migratory cells that contribute to the formation of the cardiac outflow tract and pharyngeal arch arteries. Neural crest-related developmental defects account for a large proportion of congenital heart disorders. Recently, the genetic bases for some of these disorders have been elucidated, and signaling pathways required for induction, migration and differentiation of cardiac neural crest have emerged. Bone morphogenetic proteins comprise a family of secreted ligands implicated in numerous aspects of organogenesis, including heart and neural crest development. However, it has remained generally unclear whether BMP ligands act directly on neural crest or cardiac myocytes during cardiac morphogenesis, or function indirectly by activating other cell types. Studies on BMP receptor signaling during organogenesis have been hampered by the fact that receptor knockouts often lead to early embryonic lethality. We have used a Cre/loxP system for neural crest-specific deletion of the type I receptor, ALK2, in mouse embryos. Mutant mice display cardiovascular defects, including persistent truncus arteriosus, and abnormal maturation of the aortic arch reminiscent of common forms of human congenital heart disease. Migration of mutant neural crest cells to the outflow tract is impaired, and differentiation to smooth muscle around aortic arch arteries is deficient. Moreover, in Alk2 mutants, the distal outflow tract fails to express Msx1, one of the major effectors of BMP signaling. Thus, the type I BMP receptor ALK2 plays an essential cell-autonomous role in the development of the cardiac outflow tract and aortic arch derivatives.